A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study.
Serruys, Patrick W.; Foley, David P.; Suttorp, Martin Janet al.
2002 • In Journal of the American College of Cardiology, 39 (3), p. 393-9
[en] OBJECTIVES: We sought to investigate the clinical benefit of additional stent implantation after achieving an optimal result of balloon angioplasty (BA) in long coronary lesions (>20 mm). BACKGROUND: Long coronary lesions are associated with increased early complications and late restenosis after BA. Stenting improves the early outcome, but stent restenosis is also related to both lesion length and stent length. METHODS: A total of 437 patients with a single native lesion 20 to 50 mm in length were included and underwent BA, using long balloons matched to lesion length and vessel diameter (balloon/artery ratio 1.1) to achieve a diameter stenosis (DS) <30% by on-line quantitative coronary angiography (QCA). "Bail-out stenting" was performed for flow-limiting dissections or >50% DS. Patients in whom an optimal BA result was achieved were randomized to additional stenting (using NIR stents) or no stenting. The primary end point was freedom from major adverse cardiac events (MACE) at nine months, and core laboratory QCA was performed on serial angiograms. RESULTS: Bailout stenting was necessary in 149 patients (34%) and was associated with a significantly increased risk of peri-procedural infarction (p < 0.02). Among the 288 randomized patients, the mean lesion length was 27+/-9 mm, and the vessel diameter was 2.78+/-0.52 mm. The procedural success rate was 90% for the 143 patients assigned to BA alone (control group), as compared with 93% in the 145 patients assigned to additional stenting (stent group), which resulted in a superior early minimal lumen diameter (0.54 mm, p < 0.001) and led to reduced angiographic restenosis (27% vs. 42%, p = 0.022). Freedom from MACE at nine months was 77% in both groups. CONCLUSIONS: A strategy of provisional stenting for long coronary lesions led to bailout stenting in one-third of patients, with a threefold increase in peri-procedural infarction. Additional stenting yielded a lower angiographic restenosis rate, but no reduction in MACE at nine months.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Serruys, Patrick W.
Foley, David P.
Suttorp, Martin Jan
Rensing, Benno J. W. M.
Suryapranata, Harry
Materne, Phillipe
van den Bos, Arijan
Benit, Edouard
Anzuini, Angelo
Rutsch, Wolfgang
Legrand, Victor ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie
A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study.
Meier B., Gruentzig A.R., Hollman J., Ischinger T., Bradford J.M. (1983) Does length or eccentricity of coronary stenoses influence the outcome of transluminal dilatation?. Circulation 67:497-499.
Ellis S.G., Roubin G.S., King III S.B. (1988) Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 77:372-379.
Leimgruber P.P., Roubin G.S., Hollman J. (1986) Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 73:710-717.
Rensing B.J., Hermans W.R., Vos J. (1993) Luminal narrowing after percutaneous transluminal coronary angioplasty: A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Circulation 88:975-985.
Cannon A.D., Roubin G.S., Hearn J.A., Iyer S.S., Baxley W.A., Dean L.S. (1994) Acute angiographic and clinical results of long balloon percutaneous transluminal coronary angioplasty and adjuvant stenting for long narrowings. Am J Cardiol 73:635-641.
Serruys P.W., De Jaegere P., Kiemeneij F. (1994) A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489-495.
Fishman D.L., Leon M.B., Baim D. (1994) A randomised comparison of coronary stent placement and balloon angloplasty in the treatment of coronary artery disease. N Engl J Med 331:496-501.
Kobayashi Y., De Gregorio J., Kobayashi N. (1999) Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 34:651-659.
Foley D.P., Pieper M., Wijns W. (2001) The influence of stent length on clinical and angiographic outcomes in patients' elective stenting for native coronary lesions: Final results of the MAGIC 5L study. Eur Heart J 22:1585-1593.
Kastrati A., Elezi S., Dirschinger J., Hadamitzky M., Neumann F.J., Schomig A. (1999) Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 83:1617-1622.
Foley D.P., Serruys P.W. (1996) Provisional stenting - Stent-like balloon angioplasty: Evidence to define the continuing role of balloon angioplasty for percutaneous coronary revascularization. Semin Interv Cardiol 1:269-273.
Serruys P.W., De Bruyne B., Carlier S. (2000) Randomized comparison of primary stenting and provisional balloon angioplasty guided by flow velocity measurement (DEBATE 2). Circulation 102:2930-2937.
Stone G.W., Hodgson J.M., St. Goar F.G. (1997) Improved procedural results of coronary angioplasty with intravascular ultrasound-guided balloon sizing: The CLOUT pilot trial. Circulation 95:2044-2052.
Di Mario C., Moses J.W., Anderson T.J. (2000) Randomized comparison of elective stent implantation and coronary balloon angioplasty guided by online quantitative angiography and intracoronary Doppler. Circulation 102:2938-2944.
Hermans W.R., Foley D.P., Rensing B.J. (1993) Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. Am J Cardiol 72:14-20.
Lafont A., Dubois-Rande J.L., Steg P.G. (2000) The French Randomized Optimal Stenting Trial: A prospective evaluation of provisional stenting guided by coronary velocity reserve and quantitative coronary angiography. J Am Coll Cardiol 36:404-409.
Abdelmeguid A.E., Topol E.J. (1996) The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures. Circulation 94:3369-3375.
Simoons M.L., Van den Brand M., Lincoff M. (1999) Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J 20:1112-1119.
Serruys P.W., Emanuelsson H., Van der Giessen W. (1996) Heparin-coated Palmaz-Schatz stents in human coronary arteries: Early outcome of the BENESTENT-II pilot study. Circulation 93:412-422.
De Jaegere P., Mudra H., Figulla H. (1998) Intravascular ultrasound-guided optimized stent deployment: Immediate and 6 months clinical and angiographic results from the Multicentre Ultrasound Stenting in Coronaries (MUSIC) study. Eur Heart J 19:1214-1223.
Hong M.K., Park S.W., Mintz G.S., Lee N.H., Lee C.W., Kim J.J., Park S.J. (2000) Intravascular ultrasonic predictors of angiographic restenosis after long coronary stenting. Am J Cardiol 85:441-445.
Bauters C., Hubert E., Prat A. (1998) Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 31:1291-1298.
Kastrati A., Schomig A., Elezi S. (1997) Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 30:1428-1436.
Cura F.A., Bhatt D.L., Lincoff A.M. (2000) Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions. Circulation 102:28-34.
Sousa J.E., Costa M.A., Abizaid A. (2001) Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103:192-195.
Morice M.C., Serruys P.W., Sousa J.E. (2001) The RAVEL study: A randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. Eur Heart J 22:2624.
